Our Scientific Advisory Board
We believe in nature and science. That’s why we work with industry researchers, scientists, and medical professionals to fully realize the potential of the plant.
Devinsky brings over 35 years of expertise as a world-renowned Neurologist to the Papa & Barkley Scientific Advisory Board. Devinsky is the director of NYU Langone’s Comprehensive Epilepsy Center, where he leads a large dedicated team of epileptologists and neuropsychologists who have collaborated to pioneer several techniques, including responsive neurostimulation therapy, multistage epilepsy surgery, and multiple subpial transection.
Devinsky is a graduate of Harvard Medical School and published scholar in the Journal of Epilepsia.
Dr. Rafi Gidron is a serial entrepreneur who founded and managed technology companies in multiple disciplines including fields such as telecommunications, neurotechnology and cleantech. Most notably, Gidron was involved in one of the most successful exits in Israel’s hi-tech industry: the acquisition of Chromatis Networks by Lucent in 2000.
Gidron serves as the founder and chairman of Israel Brain Technologies. Gidron holds a BSc from Tel Aviv University and a Ph.D. from Columbia University, where he also served as an associate director of NSF’s Center for Telecommunications Research.
Mitch Earleywine, Ph.D. is the Professor of Psychology at the State University of New York at Albany. He has received research grants from the National Institute on Alcohol Abuse and Alcoholism as well as the Alcoholic Beverage Medical Research Foundation.
He is a member of the NORML Advisory Board and his research has been published in over fifty scientific journals on drugs and addiction. He is the author of Understanding Marijuana, Pot Politics, and Parents’ Guide to Marijuana. He received his bachelor’s degree from Columbia University and his doctorate from Indiana University.
The Latest Cannabis Research From Our Board
What are we to make of the conflicting portrayals of a drug with historical origins dating back to 8,000 B.C.? Understanding Marijuana examines the biological, psychological, and societal impact of this controversial substance. Mitch Earleywine separates science from opinion to show how marijuana defies easy dichotomies. Tracing the medical and political debates surrounding marijuana in a balanced, objective fashion, this book is the definitive primer on our most controversial and widely used illicit substance.
Can a Pharmaceutical-Grade Marijuana Extract Treat Severe Pediatric Epilepsy? - Dr. Orrin Devinsky, M.D
An in-depth profile of Orrin Devinsky, MD, as he works with Karyn O’Brien, mother to a toddler with Severe Pediatric Epilepsy. In July 2013, a TV documentary gave her a sliver of hope. Its subject was a little girl in Colorado who suffered from severe epilepsy and had received little benefit from conventional treatments. But the girl’s seizures seemed to have been all but banished by a highly unconventional remedy: an extract of cannabis. Along with a handful of other children with similar conditions, she used a strain that was high in cannabidiol (CBD), the plant’s main nonpsychoactive chemical component, and low in intoxicating tetrahydrocannabinol (THC).
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome - Orrin Devinsky, M.D.
The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug-resistant seizures and a high mortality rate. This research paper studied cannabidiol for the treatment of drug-resistant seizures in the Dravet syndrome.